This study addresses innovative approaches to increase adherence to screening tests for colorectal and breast cancer - two cancers that have the greatest impact on female cancer mortality in the United States.The cancer burden in women could be significantly reduced by increasing participation in recommended screening for colorectal cancer (CRC) and breast cancer (BC) in all eligible women. This research tests intervention to simultaneously increase both CRC and BC screening using behavior change strategies, and also estimates the efficacy and cost-effectiveness of the interventions. Two groups of women, Group A (adherent to BC screening guidelines, but NOT to CRC screening guidelines) and Group B (non-adherent to BC \& CRC guidelines) are randomized to 1. Usual Care, 2. TIWeb, 3. CSC and 4. TIWeb +CSC.
Inclusion Criteria:
* a patient of any of the participating physicians
* not having had a fecal occult blood test (fobt) in the last 12 months
* not having had a fecal immunochemical test (fit) in the past 15 months
* not having had sigmoidoscopy more than 5 years ago
* not having had a colonoscopy more than 10 years ago
* have high-speed internet access
Exclusion Criteria
* a personal history of colorectal cancer
* a personal history of breast cancer
* a personal history of colorectal polyps
* a personal history of inflammatory bowel disease
* having any medical conditions that would prohibit a mammogram or CRC screening
* have already had CRC screening